Current Advancements in Addressing Key Challenges of Therapeutic Antibody Design, Manufacture, and Formulation.

ABSTRACT: Therapeutic antibody technology heavily dominates the biologics market and continues to present as a significant industrial interest in developing novel and improved antibody treatment strategies. Many noteworthy advancements in the last decades have propelled the success of antibody development; however, there are still opportunities for improvement. In considering such interest to develop antibody therapies, this review summarizes the array of challenges and considerations faced in the design, manufacture, and formulation of therapeutic antibodies, such as stability, bioavailability and immunological engagement. We discuss the advancement of technologies that address these challenges, highlighting key antibody engineered formats that have been adapted. Furthermore, we examine the implica

SUBMITTER: Sifniotis V 

PROVIDER: S-EPMC6640721 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature